Entity Common Stock, Shares Outstanding of ACRO BIOMEDICAL CO., LTD. from 12 May 2016 to 31 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ACRO BIOMEDICAL CO., LTD. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 May 2016 to 31 Jan 2026.
  • ACRO BIOMEDICAL CO., LTD. Entity Common Stock, Shares Outstanding for the quarter ending 31 Jan 2026 was 60,042,000.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ACRO BIOMEDICAL CO., LTD. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 60,042,000 31 Jan 2026 10-K 11 Feb 2026 2025 FY
Q3 2025 60,042,000 10 Nov 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 60,042,000 11 Jul 2025 10-Q 11 Jul 2025 2023 Q3
Q2 2023 60,042,000 0 0% 17 Jul 2023 10-K 21 Jul 2023 2022 FY
Q4 2022 60,042,000 0 0% 18 Nov 2022 10-Q 21 Nov 2022 2022 Q3
Q2 2022 60,042,000 +12,282,000 +26% 10 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 60,042,000 +12,282,000 +26% 14 Apr 2022 10-K 15 Apr 2022 2021 FY
Q4 2021 60,042,000 15 Nov 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 47,760,000 0 0% 24 May 2021 10-Q 24 May 2021 2021 Q1
Q1 2021 47,760,000 0 0% 29 Mar 2021 10-K 02 Apr 2021 2020 FY
Q3 2020 47,760,000 13 Nov 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 47,760,000 0 0% 14 Aug 2020 10-Q 19 Aug 2020 2020 Q2
Q1 2020 47,760,000 0 0% 25 Mar 2020 10-KT 27 Mar 2020 2020 FY
Q4 2019 47,760,000 0 0% 26 Dec 2019 10-K 07 Jan 2020 2019 FY
Q2 2019 47,760,000 +100,000 +0.21% 13 Aug 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 47,760,000 13 May 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 47,760,000 +100,000 +0.21% 20 Dec 2018 10-K 28 Dec 2018 2018 FY
Q2 2018 47,660,000 +500,000 +1.1% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q4 2017 47,660,000 +31,940,000 +203% 12 Jan 2018 10-K/A 16 Jan 2018 2017 FY
Q2 2017 47,160,000 +31,440,000 +200% 10 Aug 2017 10-Q 11 Aug 2017 2017 Q3
Q4 2016 15,720,000 14 Dec 2016 10-K 16 Dec 2016 2016 FY
Q2 2016 15,720,000 28 Jul 2016 10-Q 03 Aug 2016 2016 Q3
Q1 2016 15,720,000 12 May 2016 10-Q 13 May 2016 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.